2025年2月11日 · SYDNEY: Orion Minerals Limited (ASX/JSE: ORN) announced the appointment of Kevin Moxham as its new Chief Operating Officer, effective from February 10, 2025. Moxham’s appointment marks a critical juncture for the company, as it gears up to transition from exploration to mine development in South Africa’s Northern Cape region.

2025年2月11日 · ASX- and JSE-listed Orion Minerals has appointed experienced international mining executive Kevin Moxham as COO.

2025年2月11日 · Orion Minerals Limited announced the appointment of highly experienced international mining executive Kevin Moxham as Chief Operating Officer (COO). The appointment, which is effective from 10 February 2025.

2025年2月11日 · Learn about the role of Kevin Moxham, Chief Operating Officer at Orion Minerals. Full bio on The Official Board.

2025年2月11日 · Orion Minerals Limited (ASX/JSE: ORN) (Orion or the Company) is pleased to announce the appointment of highly experienced international mining executive Kevin Moxham as Chief Operating Officer...

2025年2月11日 · Orion Minerals Limited kondigde de benoeming aan van de zeer ervaren internationale mijnbouwdirecteur Kevin Moxham als Chief Operating Officer (COO). De benoeming gaat in op 10 februari 2025.

医药魔方NextPharma®全球新药数据库为您提供「拉氧头孢」药品的基本信息（药品名称、药品类别、靶点、作用机制、药品简介、研发机构、最高研发阶段、审评审批类型、外置链接）。 了解更多药品相关信息，欢迎申请试用企业版。

2025年2月12日 · Orion Minerals hat Kevin Moxham als Chief Operating Officer ernannt, mit Wirkung von Montag, nach einem Dienstag australischen Börse Einreichung. Moxham ist ein registrierter professioneller...

2025年1月7日 · Moxam is a synthetic broad spectrum, flouroquinolone derivative antibacterial agent. Moxam has in vitro activity against a wide range of Gram-positive and Gram-negative microorganisms.